Johnson and Johnson 2015 Annual Report Download - page 21

Item 6. Selected Financial Data
Summary of Operations and Statistical Data 2005-2015
(Dollars in Millions
Except Per Share Amounts) 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005
Sales to customers – U.S. $35,687 34,782 31,910 29,830 28,908 29,450 30,889 32,309 32,444 29,775 28,377
Sales to customers –
International 34,387 39,549 39,402 37,394 36,122 32,137 31,008 31,438 28,651 23,549 22,137
Total sales 70,074 74,331 71,312 67,224 65,030 61,587 61,897 63,747 61,095 53,324 50,514
Cost of products sold 21,536 22,746 22,342 21,658 20,360 18,792 18,447 18,511 17,751 15,057 14,010
Selling, marketing and
administrative expenses 21,203 21,954 21,830 20,869 20,969 19,424 19,801 21,490 20,451 17,433 17,211
Research and development
expense 9,046 8,494 8,183 7,665 7,548 6,844 6,986 7,577 7,680 7,125 6,462
In-process research and
development 224 178 580 1,163 – – – 181 807 559 362
Interest income (128) (67) (74) (64) (91) (107) (90) (361) (452) (829) (487)
Interest expense, net of
portion capitalized 552 533 482 532 571 455 451 435 296 63 54
Other (income) expense, net (2,064) (70) 2,498 1,626 2,743 (768) (526) (1,015) 534 (671) (214)
Restructuring 509 – – – 569 – 1,073 – 745 – –
50,878 53,768 55,841 53,449 52,669 44,640 46,142 46,818 47,812 38,737 37,398
Earnings before provision for
taxes on income $19,196 20,563 15,471 13,775 12,361 16,947 15,755 16,929 13,283 14,587 13,116
Provision for taxes on income 3,787 4,240 1,640 3,261 2,689 3,613 3,489 3,980 2,707 3,534 3,056
Net earnings 15,409 16,323 13,831 10,514 9,672 13,334 12,266 12,949 10,576 11,053 10,060
Add: Net loss attributable to
noncontrolling interest – – – 339 – ––––––
Net earnings attributable
to Johnson & Johnson 15,409 16,323 13,831 10,853 9,672 13,334 12,266 12,949 10,576 11,053 10,060
Percent of sales to customers 22.0% 22.0 19.4 16.1 14.9 21.7 19.8 20.3 17.3 20.7 19.9
Diluted net earnings per share
of common stock(1) $5.48 5.70 4.81 3.86 3.49 4.78 4.40 4.57 3.63 3.73 3.35
Percent return on average
shareholders’ equity 21.9% 22.7 19.9 17.8 17.0 24.9 26.4 30.2 25.6 28.3 28.2
Percent increase
(decrease) over previous
year:
Sales to customers (5.7)% 4.2 6.1 3.4 5.6 (0.5) (2.9) 4.3 14.6 5.6 6.7
Diluted net earnings per share (3.9)% 18.5 24.6 10.6 (27.0) 8.6 (3.7) 25.9 (2.7) 11.3 22.3
Supplementary balance
sheet data:
Property, plant and
equipment, net 15,905 16,126 16,710 16,097 14,739 14,553 14,759 14,365 14,185 13,044 10,830
Additions to property, plant
and equipment 3,463 3,714 3,595 2,934 2,893 2,384 2,365 3,066 2,942 2,666 2,632
Total assets(2) 133,411 130,358 131,754 121,347 113,644 102,908 94,682 84,912 80,954 70,556 58,864
Long-term debt 12,857 15,122 13,328 11,489 12,969 9,156 8,223 8,120 7,074 2,014 2,017
Operating cash flow 19,279 18,471 17,414 15,396 14,298 16,385 16,571 14,972 15,022 14,248 11,799
Common stock
information
Dividends paid per share $2.95 2.76 2.59 2.40 2.25 2.11 1.93 1.795 1.62 1.455 1.275
Shareholders’ equity per
share 25.82 25.06 26.25 23.33 20.95 20.66 18.37 15.35 15.25 13.59 13.01
Market price per share (year-
end close) $102.72 105.06 92.35 69.48 65.58 61.85 64.41 58.56 67.38 66.02 60.10
Average shares outstanding
(millions)
– basic 2,771.8 2,815.2 2,809.2 2,753.3 2,736.0 2,751.4 2,759.5 2,802.5 2,882.9 2,936.4 2,973.9
– diluted 2,812.9 2,863.9 2,877.0 2,812.6 2,775.3 2,788.8 2,789.1 2,835.6 2,910.7 2,961.0 3,002.8
Employees (thousands) 127.1 126.5 128.1 127.6 117.9 114.0 115.5 118.7 119.2 122.2 115.6
(1) Attributable to Johnson & Johnson.
(2) Amounts have been reclassified to conform to current year presentation.
Johnson & Johnson 2015 Annual Report •9